Solar energy greener when home grown


Solar panels manufactured overseas can have twice the carbon footprint of those produced domestically, a new life cycle analysis (LCA) of photovoltaics has shown.

So far, similar LCAs have focused on Europe or North America – where the use of solar energy is highest and the majority of R&D is concentrated – and assumed that the materials are manufactured in-country. But in reality 80% of silicon-based photovoltaics are manufactured in Asia, where there may be fewer environmental controls. To investigate the impact of this, a team led by Fengqi You at Northwestern University, US, carried out LCAs for photovoltaic modules under two different scenarios: those that are manufactured and installed in Europe, and those that are manufactured in China, then transported to Europe and installed.

The energy payback time – a measure of the time it takes the modules to generate the energy required to make them – rose from 1.6 to 2.3 years for multi-silicon photovoltaics when manufactured in China. Their carbon footprint more than doubled – 69.2 COequivalents/kWh compared with 31.8 COequivalents/kWh for those made in Europe. The team say this is mainly due to the use of coal to generate electricity in China, as some parts of the manufacturing process – such as the production of purified silicon – have high electricity demands. They suggest this effect should be recognised in Europe and the US, and addressed with a carbon tax on imported photovoltaics.


Related Content

Burn to boost silver salvage from solar cells

16 February 2016 Research

news image

Improved sterling recovery cuts environmental impact of solar cell recycling

Green houses

5 March 2013 Premium contentFeature

news image

Fiona Case discovers how chemistry can help reduce the energy consumption of our houses

Most Commented

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels

Large HIV vaccine trial to launch in South Africa

24 May 2016 News and Analysis

news image

US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November